Lu AG13909

· H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lu AG13909, covering 2026-02-18 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia [Phase 1, Phase 2]